Comment on: A British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom

Por Roos, Jonathan C. P., Murthy, Rachna
Publicado no Eye (Lond) (2018)

Sirolimus (rapamycin) for the targeted treatment of the fibrotic sequelae of Graves’ orbitopathy

Por Roos, Jonathan C. P., Murthy, Rachna
Publicado no Eye (Lond) (2019)

Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy

Por Roos, Jonathan C. P., Paulpandian, Vignesh, Murthy, Rachna
Publicado no Eye (Lond) (2018)

Clinical pathophysiology of thyroid eye disease: The Cone Model

Por Meyer, Paul, Das, Tilak, Ghadiri, Nima, Murthy, Rachna, Theodoropoulou, Sofia
Publicado no Eye (Lond) (2019)

Improving aseptic injection standards in aesthetic clinical practice

Por Murthy, Rachna, Eccleston, David, Mckeown, Darren, Parikh, Apul, Shotter, Sophie
Publicado no Dermatol Ther (2020)

T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study

Por Das, Tilak, Roos, Jonathan C. P., Patterson, Andrew J., Graves, Martin J., Murthy, Rachna
Publicado no Eye (Lond) (2018)

Immune reconstitution after alemtuzumab therapy for multiple sclerosis triggering Graves’ orbitopathy: a case series

Por Roos, Jonathan C. P., Moran, Carla, Chatterjee, V. Krishna, Jones, Joanne, Coles, Alasdair, Murthy, Rachna
Publicado no Eye (Lond) (2018)

Suture midface suspension

Por Ugurbas, Suat H, Goldberg, Robert A, McCann, John D, Shorr, Norman, Murthy, Rachna, Ben Simon, Guy J
Publicado em 2006